JPMorgan plans digital dual direction contingent buffer notes on stock

By Susanna Moon

Chicago, April 12 – JPMorgan Chase & Co. plans to price digital dual directional contingent buffered notes due Oct. 18, 2017 linked to Allergan plc shares, according to a 424B2 filing with the Securities and Exchange Commission.

If the stock gains or falls by up to the 20% contingent buffer, the payout at maturity will be par plus at least 16%. The exact contingent digital return will be set at pricing.

If Allergan shares fall by more than the contingent buffer, investors will be fully exposed to any losses.

J.P. Morgan Securities LLC is the agent.

The notes will price on April 13 and settle on April 18.

The Cusip number is 46625HRC6.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.